Memphis Pharmaceuticals (MPCI.CA) - Company’s Response to the Report of the Central Auditing Organization
Company Name : Memphis Pharmaceuticals
ISIN Code : EGS38351C010
Reuters Code : MPCI.CA
Company’s response to the report of the Central Auditing Organization on the financial statements for the financial period ending on 31/12/2023
Company's Response (895 KB)
ISIN Code : EGS38351C010
Reuters Code : MPCI.CA
Company’s response to the report of the Central Auditing Organization on the financial statements for the financial period ending on 31/12/2023
Company's Response (895 KB)
Comments